06.30.17
Tarrytown, NY
www.prestigebrandsinc.com
Sales: $308 million (estimated) for household and personal care products.
Corporate sales: $882 million.
Key Personnel: Ron Lombardi, chief executive officer; Jean Boyko, chief scientific officer; Tim Connors, chief marketing officer.
Major Products: Nix, Summer’s Eve, Compound W, Clear Eyes, BC, DenTek and Goody’s
New Products: Nix Ultra & Nix Ultra Kit, Clear Eyes Pure Relief for Dry Eye Clear Eyes Pure Relief for Multi-Symptom, Luden’s Green Apple, Summer’s Eve Simply Washes & Cloths (Mandarin Blossom, Coconut Water), Compound W Advanced w/ Boosting Gel & Pad, Compound W Dual Action.
Comments: Prestige Brands has fully integrated its January 2017 acquisition of Fleet Laboratories, including its first manufacturing facility located in Lynchburg, VA. DenTek is continuing to boost business at the company. Reported revenues for the second quarter of fiscal 2017 jumped 4.4% to $215.1 million. Reported revenues for the six-month period ended Sept. 30, 2016 rose 6.6% to $424.6 million. The results, according to the firm, reflect consumption increases across its invest-for-growth portfolio and the addition of the DenTek business.
Prestige Brands also rolled out a major launch for Summer 2017: Summer’s Eve personal care wipes and cleansers in exotic scents such as Mandarin Blossom and Coconut Water.
In more feminine care news, Natureplex—an over-the-counter drug manufacturer headquartered in Olive Branch, MI—has licensed feminine hygiene brand Massengill from Prestige Brands Holdings. Massengill, which has been around since the 1970s, holds the No. 2 position in the category. The company said it plans to work diligently on transitioning customers over in early 2017, as well as working on new products to complement the brand.
Also in 2017, the company’s board elected Ron Lombardi as chairman. Gary E. Costley will remain the company’s lead independent director.
Lombardi, president and CEO, stated, “In fiscal 2018, we expect continued organic growth in our existing business and incremental revenues from the acquisition of Fleet to drive growth.”
www.prestigebrandsinc.com
Sales: $308 million (estimated) for household and personal care products.
Corporate sales: $882 million.
Key Personnel: Ron Lombardi, chief executive officer; Jean Boyko, chief scientific officer; Tim Connors, chief marketing officer.
Major Products: Nix, Summer’s Eve, Compound W, Clear Eyes, BC, DenTek and Goody’s
New Products: Nix Ultra & Nix Ultra Kit, Clear Eyes Pure Relief for Dry Eye Clear Eyes Pure Relief for Multi-Symptom, Luden’s Green Apple, Summer’s Eve Simply Washes & Cloths (Mandarin Blossom, Coconut Water), Compound W Advanced w/ Boosting Gel & Pad, Compound W Dual Action.
Comments: Prestige Brands has fully integrated its January 2017 acquisition of Fleet Laboratories, including its first manufacturing facility located in Lynchburg, VA. DenTek is continuing to boost business at the company. Reported revenues for the second quarter of fiscal 2017 jumped 4.4% to $215.1 million. Reported revenues for the six-month period ended Sept. 30, 2016 rose 6.6% to $424.6 million. The results, according to the firm, reflect consumption increases across its invest-for-growth portfolio and the addition of the DenTek business.
Prestige Brands also rolled out a major launch for Summer 2017: Summer’s Eve personal care wipes and cleansers in exotic scents such as Mandarin Blossom and Coconut Water.
In more feminine care news, Natureplex—an over-the-counter drug manufacturer headquartered in Olive Branch, MI—has licensed feminine hygiene brand Massengill from Prestige Brands Holdings. Massengill, which has been around since the 1970s, holds the No. 2 position in the category. The company said it plans to work diligently on transitioning customers over in early 2017, as well as working on new products to complement the brand.
Also in 2017, the company’s board elected Ron Lombardi as chairman. Gary E. Costley will remain the company’s lead independent director.
Lombardi, president and CEO, stated, “In fiscal 2018, we expect continued organic growth in our existing business and incremental revenues from the acquisition of Fleet to drive growth.”